Treatment for problematic sexual behavior in preteen children
Official title: Treatment for Problematic Sexual Behavior of Preteen Children
Run by Milton S. Hershey Medical Center · NCT05514730 · Data updated 2026-11-12
This study is testing a new treatment for preteen children with problematic sexual behavior to see if it works better than the usual methods.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 4 Years to 12 Years |
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | Milton S. Hershey Medical Center Academic / other |
| Locations | 1 site (Harrisburg, Pennsylvania) |
| Status | Recruiting |
| Started | January 9, 2023 |
| Main results expected | June 2028 |
| Study ends | June 2028 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT05514730 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 4 to 12 years who exhibit problematic sexual behavior and have a caregiver willing to participate in the treatment.
✕Probably not a fit
Patients who may not benefit from this study include those whose caregivers report lower levels of problematic behavior or who are suspected of perpetrating child sexual abuse.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates a new intervention called Phase-Based Treatment (PBT) for addressing problematic sexual behavior (PSB) in preteen children. The study aims to compare the effectiveness of PBT against standard treatment approaches through a randomized controlled trial (RCT). Previous pilot studies have shown promising results, indicating that PBT may lead to significant improvements in managing PSB. The trial will also assess feasibility, participant satisfaction, and recruitment strategies for future larger-scale studies.
Why it matters
Potential benefit: If successful, this treatment could provide a more effective intervention for managing problematic sexual behavior in preteen children, leading to better outcomes for affected families.
How similar studies have gone: While previous studies have shown positive outcomes with similar interventions, this RCT represents a novel approach to rigorously evaluate the effectiveness of PBT.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Child between ages 4 and 12 years * Caregiver reports a raw score on the CSBI greater than 4. * A primary caregiver is willing to participate in treatment. * Child earns a scaled score above 69 on the Kaufman Brief Intelligence Test (KBIT-2) * Child proficient in spoken English * Caregiver proficient in written and spoken English. Exclusion Criteria: * Child is less than 4 years of age or older than 12 years of age. * Caregiver reports a score on the CSBI lower than 4 * A primary caregiver is unwilling to participate in treatment. * Child scored lower than 70 on the KBIT-2. * The primary caregiver is suspected of perpetrating child sexual abuse. * Child not proficient in spoken English. * Caregiver not proficient in both written and spoken English.
Where it's running
-
Penn State Hershey Medical Center-TLC Research and Treatment Center
Harrisburg, Pennsylvania, United States Recruiting
Study contacts
- Study coordinator: Brian Allen, PsyD
- Email: ballen1@pennstatehealth.psu.edu
- Phone: 7175314100
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
This trial tests whether adding eflornithine (DFMO) as extra or maintenance therapy can improve survival for young people with Ewing sarcoma or osteosarcoma.
-
College student–delivered cognitive behavioral therapy for rural high school students
This project will test whether cognitive-behavioral therapy delivered by trained college students can help high school students in rural Schuylkill County who have symptoms of depression, anxiety, or stress.
-
An AI chatbot to help teens and young adults with eating disorders manage anxiety about weight gain
This project will test an AI-powered chatbot that delivers exposure-based exercises to help adolescents and young adults in a partial hospitalization program reduce anxiety about weight gain.
-
Virtual exposure treatment for adolescents with anorexia nervosa
This project will try virtual exposure therapy to help 14–17-year-olds with anorexia nervosa face and tolerate anxiety about weight gain.
-
CBG/CBD oil for chemotherapy-induced peripheral neuropathy
This will try a CBG/CBD oil to see if it safely reduces pain, numbness, or other nerve symptoms in adults who developed peripheral neuropathy after platinum-based chemotherapy for gastrointestinal cancers.
-
Allogeneic stem cell transplant with low-dose post-transplant cyclophosphamide to prevent graft-versus-host disease.
This study tests whether giving low-dose (25 mg/kg) cyclophosphamide on days +3 and +4 after allogeneic peripheral blood stem cell transplant can prevent GVHD in adults with blood cancers who receive reduced-intensity or non-myeloablative conditioning.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.